John Ransom
Stock Analyst at Raymond James
(3.68)
# 683
Out of 4,874 analysts
227
Total ratings
64.65%
Success rate
15.28%
Average return
Main Sectors:
Stocks Rated by John Ransom
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $330.74 | +16.41% | 18 | May 5, 2025 | |
UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $304.12 | +77.56% | 13 | Apr 21, 2025 | |
RDNT RadNet | Upgrades: Strong Buy | $85 → $65 | $56.96 | +14.12% | 11 | Mar 5, 2025 | |
HCA HCA Healthcare | Downgrades: Market Perform | n/a | $379.37 | - | 21 | Nov 22, 2024 | |
THC Tenet Healthcare | Downgrades: Outperform | $195 | $172.27 | +13.19% | 17 | Nov 22, 2024 | |
CYH Community Health Systems | Downgrades: Underperform | n/a | $3.47 | - | 8 | Nov 22, 2024 | |
SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $80.52 | +5.57% | 12 | Nov 1, 2024 | |
GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $5.02 | +99.20% | 2 | May 16, 2024 | |
EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $121.81 | -22.01% | 15 | Apr 26, 2024 | |
WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $11.42 | - | 7 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $97.96 | - | 14 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $242.49 | - | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $20.32 | -1.57% | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $27.55 | +8.89% | 12 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $13.79 | -12.98% | 9 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $68.18 | +24.67% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $114.54 | -8.33% | 8 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $4.87 | +105.34% | 4 | Aug 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.81 | - | 7 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.73 | - | 11 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.54 | - | 7 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $22.05 | +353.51% | 8 | Aug 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $56.40 | - | 2 | Feb 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $27.03 | - | 2 | Dec 20, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $141.14 | - | 8 | Nov 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.70 | - | 2 | Aug 9, 2017 |
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $330.74
Upside: +16.41%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $304.12
Upside: +77.56%
RadNet
Mar 5, 2025
Upgrades: Strong Buy
Price Target: $85 → $65
Current: $56.96
Upside: +14.12%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $379.37
Upside: -
Tenet Healthcare
Nov 22, 2024
Downgrades: Outperform
Price Target: $195
Current: $172.27
Upside: +13.19%
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.47
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $80.52
Upside: +5.57%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $5.02
Upside: +99.20%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $121.81
Upside: -22.01%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.42
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $97.96
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $242.49
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $20.32
Upside: -1.57%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $27.55
Upside: +8.89%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $13.79
Upside: -12.98%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $68.18
Upside: +24.67%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $114.54
Upside: -8.33%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $4.87
Upside: +105.34%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.81
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.73
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.54
Upside: -
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $22.05
Upside: +353.51%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $56.40
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $27.03
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $141.14
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $21.70
Upside: -